+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 39 Pages
  • June 2023
  • GlobalData
  • ID: 1292309
Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nanjing Pharmaceutical Co Ltd (NPC) focuses on the distribution of a wide range of pharmaceutical products and other products. It provides a range of pharmaceutical supply chain services and health chain services. The company also provides traditional Chinese medicine, logistics services and property management. The company offers its products to hospitals, pharmacies, community health institutions, chain pharmacies, rural township hospitals, clinics, other non-public medical institutions, and commercial distribution enterprises. The company provides its services to Anhui, Jiangsu, Hubei, Sichuan, Yunnan, and Fujian provinces covering several cities across China. The company is headquartered in Nanjing, Jiangsu, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Nanjing Pharmaceutical Co Ltd - Key Facts
  • Nanjing Pharmaceutical Co Ltd - Key Employees
  • Nanjing Pharmaceutical Co Ltd - Key Employee Biographies
  • Nanjing Pharmaceutical Co Ltd - Major Products and Services
  • Nanjing Pharmaceutical Co Ltd - History
  • Nanjing Pharmaceutical Co Ltd - Company Statement
  • Nanjing Pharmaceutical Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Nanjing Pharmaceutical Co Ltd - Business Description
  • Business Segment: Main Business
  • Overview
  • Performance
  • Business Segment: Other Business
  • Overview
  • Performance
  • Geographical Segment: Anhui
  • Performance
  • Geographical Segment: Fujian
  • Performance
  • Geographical Segment: Hubei
  • Performance
  • Geographical Segment: Jiangsu
  • Performance
  • Geographical Segment: Other
  • Performance
  • Nanjing Pharmaceutical Co Ltd - Corporate Strategy
  • Nanjing Pharmaceutical Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Nanjing Pharmaceutical Co Ltd - Strengths
  • Nanjing Pharmaceutical Co Ltd - Weaknesses
  • Nanjing Pharmaceutical Co Ltd - Opportunities
  • Nanjing Pharmaceutical Co Ltd - Threats
  • Nanjing Pharmaceutical Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Nanjing Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Nanjing Pharmaceutical Co Ltd, Key Facts
  • Nanjing Pharmaceutical Co Ltd, Key Employees
  • Nanjing Pharmaceutical Co Ltd, Key Employee Biographies
  • Nanjing Pharmaceutical Co Ltd, Major Products and Services
  • Nanjing Pharmaceutical Co Ltd, History
  • Nanjing Pharmaceutical Co Ltd, Subsidiaries
  • Nanjing Pharmaceutical Co Ltd, Key Competitors
  • Nanjing Pharmaceutical Co Ltd, Ratios based on current share price
  • Nanjing Pharmaceutical Co Ltd, Annual Ratios
  • Nanjing Pharmaceutical Co Ltd, Interim Ratios
  • Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Nanjing Pharmaceutical Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Nanjing Pharmaceutical Co Ltd, Performance Chart (2018 - 2022)
  • Nanjing Pharmaceutical Co Ltd, Ratio Charts
  • Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Nanjing Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • China Meheco Group Co Ltd
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Sihuan Pharmaceutical Holdings Group Ltd
  • Fosun International Ltd
  • Sinopharm Group Co Ltd